Avian Influenza Studies In Lebanon

Status Completed

Clinical Trial Summary

The highly pathogenic avian influenza (HPAI) H5N1 virus arrived in the Middle East in 2005 and has since established itself in local domestic birds and is now considered endemic in several Middle Eastern countries.Few studies indicate the presence of low pathogenicity avian influenza (LPAI) viruses of the H9 type among Lebanese poultry and wild birds. These studies also provide some evidence suggesting that humans exposed to these sick birds are showing elevated antibody titers against these LPAI H9 viruses.

This study will focus on the following objectives:

- To determine the seroprevalence of AI in poultry-exposed and non-exposed human populations.

- To identify risk factors associated with AI infections in occupationally-exposed poultry workers.

- To conduct nation-wide cross-sectional surveillance for AI viruses among domestic birds in low biosecurity farms and backyard flocks.

Clinical Trial Description

This study will examine the sera of 200 poultry-exposed adults and 50 adult controls and administer questionnaires to identify risk factors for AI infections in human beings.Study volunteers will be interviewed regarding their exposures, medical history, and behaviors using a close-ended questionnaire specifically tailored for this study. A blood sample will be collected from every participant to verify presence of antibodies against the viruses under study. All study materials are in English and Arabic. Along side the human aspect of the study, specimens will be collected from the birds that the individual handles.

This study hypothesizes that they will find evidence of previous infection with these viruses among poultry workers. Furthermore, the study team will collect animal specimens from the farms of the study volunteers and determine the types of Avian Influenza viruses that they harbour. ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01107262
Study type	Observational
Source	St. Jude Children's Research Hospital
Contact
Status	Completed
Phase	N/A
Start date	July 2009
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04074928` - Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects	Phase 3
Completed	`NCT03321968` - Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults	Phase 3
Completed	`NCT04644484` - A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety	Phase 3
Completed	`NCT00984945` - Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults	Phase 1
Completed	`NCT00734175` - Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine	Phase 1
Completed	`NCT00516035` - Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults	Phase 1
Active, not recruiting	`NCT05284097` - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study	Phase 2
Completed	`NCT03739112` - Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly	Phase 3
Recruiting	`NCT06113757` - Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease	N/A
Completed	`NCT01991587` - Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults	Phase 1/Phase 2
Completed	`NCT03294135` - The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine	Phase 4
Active, not recruiting	`NCT02545517` - A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens	Phase 3
Active, not recruiting	`NCT05619770` - Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects	Phase 1
Not yet recruiting	`NCT01289301` - Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant	Phase 4
Active, not recruiting	`NCT01055990` - Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients	Phase 2
Completed	`NCT00980447` - Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults	Phase 2
Completed	`NCT01842997` - Safety of H1N1 Influenza Vaccination in Pregnant Women	Phase 4
Completed	`NCT00380237` - Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)	Phase 1
Completed	`NCT00219453` - Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination	Phase 1
Completed	`NCT02548078` - A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children	Phase 2